Previously treated cases tested for RR-/MDR-TB in Costa Rica

Costa Rica: Previously treated cases tested for RR-/MDR-TB was 62.0% in 2024. ◆ Volatile

Latest (2024)
62.0%
Change on year
down 38.0%
World rank
135th
of 180 countries
All-time high
100.0%
in 2006
All-time low
0.0%
in 2013
Years of data
16
2005–2024

Previously treated cases tested for RR-/MDR-TB in Costa Rica, 2005–2024

0204060801002005201420242005: 2.22006: 1002008: 1002011: 622012: 1002013: 02014: 5.32015: 5.62016: 02017: 812018: 02019: 1002021: 292022: 282023: 1002024: 62

Source: World Health Organization, Global Health Observatory.

Analysis

Costa Rica recorded 62.0% for previously treated cases tested for rr-/mdr-tb in 2024.

That represents a change of down 38.0% on the previous year and up 1,069.8% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Costa Rica peaked at 100.0% in 2006 and was at its lowest, 0.0%, in 2013.

Costa Rica ranks 135th of 180 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Costa Rica, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Costa Rica, 2005 to 2024.
Year Value Change
2005 2.2%
2006 100.0% +4445.5%
2008 100.0% +0.0%
2011 62.0% -38.0%
2012 100.0% +61.3%
2013 0.0% -100.0%
2014 5.3%
2015 5.6% +5.7%
2016 0.0% -100.0%
2017 81.0%
2018 0.0% -100.0%
2019 100.0%
2021 29.0% -71.0%
2022 28.0% -3.4%
2023 100.0% +257.1%
2024 62.0% -38.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 67.4% 2.2% 100.0% 3
2010s 39.3% 0.0% 100.0% 9
2020s 54.8% 28.0% 100.0% 4

Countries ranked near Costa Rica

  1. 134 Madagascar 69.0% compare
  2. 136 Panama 61.0% compare
  3. 136 Argentina 61.0% compare
  4. 136 Cuba 61.0% compare
  5. 136 Austria 61.0% compare

See the full ranking of 192 places →

More health data for Costa Rica

All data for Costa Rica →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Costa Rica?
Previously treated cases tested for rr-/mdr-tb in Costa Rica was 62.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Costa Rica?
The highest recorded value was 100.0% in 2006.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Costa Rica?
The lowest recorded value was 0.0% in 2013.
How does Costa Rica rank for previously treated cases tested for rr-/mdr-tb?
Costa Rica ranks 135th out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Costa Rica?
Over the last ten years it is up 1,069.8%. The long-run trend across the full record is volatile.
Where does this Costa Rica data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Costa Rica. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 01 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/costa-rica/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/costa-rica/">Previously treated cases tested for RR-/MDR-TB in Costa Rica</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
192 places, 3,071 data points, 2005–2024
Last refreshed